Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term

Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism

(2013) Madeleine Verhovsek et al.   ANNALS OF INTERNAL MEDICINE

Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism

(2013) Marc Carrier   ANNALS OF INTERNAL MEDICINE

Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines

(2012) Gordon H. Guyatt et al.   CHEST

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy

(2012) Shannon M. Bates et al.   CHEST

Antithrombotic Therapy for VTE Disease

(2012) Clive Kearon et al.   CHEST

Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH

(2012) T. BAGLIN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis

(2011) M. CARRIER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Which patients with unprovoked VTE should receive extended anticoagulation? the minority

(2011) Marco P. Donadini et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden

(2011) Bengt Zöller et al.   LANCET

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is Thrombophilia Testing Useful?

(2011) S. Middeldorp   Hematology-American Society of Hematology Education Program

Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor

(2010) Alfonso Iorio et al.   ARCHIVES OF INTERNAL MEDICINE

Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism

(2010) Gottfried Novacek et al.   GASTROENTEROLOGY

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis

(2010) T. BAGLIN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Hormone therapies and venous thromboembolism: where are we now?

(2010) A. VAN HYLCKAMA VLIEG et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Risk of recurrent venous thromboembolism after a first oestrogen-associated episode

(2010) Grégoire Le Gal et al.   THROMBOSIS AND HAEMOSTASIS

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

(2009) W. M. Lijfering et al.   BLOOD

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

(2008) M. A. Rodger et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Recurrent Thrombosis and Survival After a First Venous Thrombosis of the Upper Extremity

(2008) L.E. Flinterman et al.   CIRCULATION

Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study

(2008) E. R. POMP et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS